Hepatitis C (englisch)

Boceprevir Based Triple Therapy in Combination with Peginterferon alfa-2a plus Ribavirin (P/R) under Real Life Conditions in Treatment Naïve Patients Infected with Chronic Hepatitis C, Genotype 1: An Interim Analysis at Week 12 after Start of Treatment . . . vorgestellt anlässlich der Digestive Disease Week 2013 (DDW) in Orlando (USA).

Zurück